-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
What Type Of Shareholders Own The Most Number of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Shares?
What Type Of Shareholders Own The Most Number of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Shares?
A look at the shareholders of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership over time. Warren Buffett said that he likes "a business with enduring competitive advantages that is run by able and owner-oriented people." So it's nice to see some insider ownership, because it may suggest that management is owner-oriented.
CK Life Sciences Int'l. (Holdings) has a market capitalization of HK$8.1b, so we would expect some institutional investors to have noticed the stock. In the chart below, we can see that institutions don't own many shares in the company. Let's take a closer look to see what the different types of shareholders can tell us about CK Life Sciences Int'l. (Holdings).
See our latest analysis for CK Life Sciences Int'l. (Holdings)
SEHK:775 Ownership Breakdown July 25th 2022What Does The Lack Of Institutional Ownership Tell Us About CK Life Sciences Int'l. (Holdings)?
Institutional investors often avoid companies that are too small, too illiquid or too risky for their tastes. But it's unusual to see larger companies without any institutional investors.
There are multiple explanations for why institutions don't own a stock. The most common is that the company is too small relative to funds under management, so the institution does not bother to look closely at the company. On the other hand, it's always possible that professional investors are avoiding a company because they don't think it's the best place for their money. CK Life Sciences Int'l. (Holdings) might not have the sort of past performance institutions are looking for, or perhaps they simply have not studied the business closely.
SEHK:775 Earnings and Revenue Growth July 25th 2022Hedge funds don't have many shares in CK Life Sciences Int'l. (Holdings). The company's largest shareholder is CK Hutchison Holdings Limited, with ownership of 45%. Ka-shing Li is the second largest shareholder owning 22% of common stock, and Triluck Assets Limited holds about 7.5% of the company stock.
A more detailed study of the shareholder registry showed us that 2 of the top shareholders have a considerable amount of ownership in the company, via their 67% stake.
Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.
Insider Ownership Of CK Life Sciences Int'l. (Holdings)
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.
Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.
Our information suggests that insiders maintain a significant holding in CK Life Sciences Int'l., (Holdings) Inc.. Insiders own HK$1.8b worth of shares in the HK$8.1b company. That's quite meaningful. Most would say this shows a good degree of alignment with shareholders, especially in a company of this size. You can click here to see if those insiders have been buying or selling.
General Public Ownership
The general public-- including retail investors -- own 24% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.
Private Company Ownership
It seems that Private Companies own 7.5%, of the CK Life Sciences Int'l. (Holdings) stock. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.
Public Company Ownership
Public companies currently own 45% of CK Life Sciences Int'l. (Holdings) stock. We can't be certain but it is quite possible this is a strategic stake. The businesses may be similar, or work together.
Next Steps:
It's always worth thinking about the different groups who own shares in a company. But to understand CK Life Sciences Int'l. (Holdings) better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 4 warning signs with CK Life Sciences Int'l. (Holdings) (at least 3 which are a bit concerning) , and understanding them should be part of your investment process.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
看看CK Life Science Int‘l,(Holdings)Inc.(HKG:775)的股東就能知道哪個集團最有權勢。一般來説,隨着公司的成長,機構會增加他們的持股。相反,隨着時間的推移,內部人士往往會減少他們的持股。沃倫·巴菲特説,他喜歡“一家由有能力、以所有者為導向的人經營的、具有持久競爭優勢的企業”。因此,看到一些內部人持股是件好事,因為這可能表明管理層是以所有者為導向的。
CK生命科學國際(控股)的市值為81億港元,因此我們預計一些機構投資者已經注意到了這隻股票。在下面的圖表中,我們可以看到,機構在該公司擁有的股份並不多。讓我們仔細看看不同類型的股東能告訴我們關於CK Life Science Int.(Holdings)的情況。
查看我們對CK生命科學國際公司的最新分析。
聯交所:775所有權明細2022年7月25日缺乏機構所有權告訴了我們關於CK生命科學國際(控股)的什麼?
機構投資者往往會避開那些規模太小、流動性太差或風險太高的公司,這些公司對他們的口味來説太小了。但在沒有任何機構投資者的情況下,看到較大的公司並不常見。
對於機構為何不持有股票,有多種解釋。最常見的是,相對於管理下的資金,該公司規模太小,因此該機構不會費心密切關注該公司。另一方面,專業投資者總是可能會避開一家公司,因為他們認為這不是他們投資的最佳地方。CK生命科學國際(控股)可能沒有機構所尋找的那種過去的業績,或者他們只是沒有仔細研究過這項業務。
聯交所:775盈利及收入增長2022年7月25日對衝基金在CK Life Science Int‘l.(Holdings)的股份並不多。該公司最大股東為長和控股有限公司,持股45%.理想汽車嘉誠為第二大股東,持有22%的普通股,Triluck Assets Limited持有約7.5%的公司股份。
對股東登記的更詳細的研究表明,兩個最大的股東通過他們67%的股份在公司擁有相當大的所有權。
研究機構持股是衡量和篩選股票預期表現的好方法。通過研究分析師的情緒,也可以達到同樣的效果。目前,我們沒有注意到分析師對該股的報道,因此該公司不太可能被廣泛持有。
CK生命科學國際(控股)的內部人士所有權
不同國家對內部人的定義可能略有不同,但董事會成員總是算數的。公司管理層對董事會負責,董事會應代表股東的利益。值得注意的是,有時最高層管理人員本身也是董事會成員。
大多數人認為內部人持股是積極的,因為它可以表明董事會與其他股東很好地結盟。然而,在某些情況下,太多的權力集中在這個羣體中。
我們的信息顯示,內部人士持有CK生命科學國際(控股)有限公司的大量股份。在這家市值81億港元的公司,內部人士持有價值18億港元的股票。這是很有意義的。大多數人會説,這表明與股東的關係很好,特別是在這樣一家規模如此大的公司。你可以點擊這裏,看看這些內部人士是一直在買入還是賣出。
一般公有制
包括散户投資者在內的普通公眾持有該公司24%的股份,因此不能輕易忽視。儘管這種規模的所有權可能不足以影響有利於他們的政策決定,但他們仍然可以對公司政策產生集體影響。
私營公司所有權
看起來私營公司持有CK生命科學國際(控股)公司7.5%的股份。或許有必要對此進行更深入的研究。如果關聯方,如內部人士,對這些私營公司中的一家有利害關係,則應在年報中披露。私營公司也可能對該公司擁有戰略利益。
上市公司所有權
上市公司目前持有CK生命科學國際(控股)公司45%的股份。我們不能確定,但很有可能這是一個戰略利益攸關方。這些業務可能是相似的,也可能是合作的。
接下來的步驟:
擁有一家公司股票的不同集團總是值得考慮的。但為了更好地瞭解CK生命科學國際(控股),我們需要考慮許多其他因素。例如,考慮一下無處不在的投資風險幽靈。我們已經確定了4個警告信號與CK Life Science Int‘l(Holdings)(至少有3家有些擔心)合作,瞭解它們應該是你投資過程的一部分。
當然了,如果你把目光投向別處,你可能會發現這是一筆很棒的投資。所以讓我們來看看這個免費有趣的公司名單。
注:本文中的數字是使用過去12個月的數據計算的,指的是截至財務報表日期的最後一個月的12個月期間。這可能與全年的年度報告數字不一致。
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧